about
Nutrition and Gastrointestinal DiseaseThe potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer preventionDo altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyXenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde.Patterns and mechanisms of localized bone invasion by tumors: studies with squamous carcinomas of the head and neck.Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancerIncreased cell membrane arachidonic acid in experimental colorectal tumours.Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues.Estimation and characterization of prostaglandins in the human gastrointestinal tract.Cyclo-oxygenase 2 inhibition in colorectal cancer therapy.Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinomaPhysical activity and colorectal cancer.Mechanism of inhibition of tumour growth by aspirin and indomethacinProstaglandin-like material extracted from squamous carcinomas of the head and neck.Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas.Inhibitory effect of sulindac against chemically-induced primary colonic tumors by N-methyl-N-nitrosourea in mice.Polyisoprenylated methylated protein methyl esterase is both sensitive to curcumin and overexpressed in colorectal cancer: implications for chemoprevention and treatment.Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.Fighting cancer with red wine? Molecular mechanisms of resveratrol.The contribution of prostaglandins in the muscle of human isolated small intestine to neurogenic responses.Prostaglandins and ulcerative colitis.Delayed diagnosis of Ewing's sarcoma of the right humerus initially treated as chronic osteomyelitis: a case report.Aspirin and the prevention of colorectal cancer: a review of the evidence.Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma.Modification of the carcinogenic process in colorectal cancer by endogenous and exogenous factors: effect of colestipol hydrochloride on tumors induced by dimethylhydrazine.Suppressive effect of low amounts of safflower and perilla oils on diethylnitrosamine-induced hepatocarcinogenesis in male F344 rats.Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome.Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ω-3 fatty acid rich perilla oil.Aspirin and risk of fatal colon cancer.Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer.The epidemiology of physical activity and cancer.A mathematical computer stimulation model for the development of colonic polyps and colon cancer.Distribution and metabolism of dihomo-gamma-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats.
P2860
Q22241264-25B64649-7B47-4060-862C-56E643775B13Q28165951-9A54875A-1B0A-4790-95A9-DEEF5CD13B74Q28195582-154D6ABA-479B-4350-B9BF-10F129019EE7Q28217572-69035252-9BF5-43C2-8DAC-073A5F36C21BQ33898260-8DA8F64C-34F8-4AD7-9B11-7F61A1336956Q34051054-D1FBD474-D167-4FE3-A16E-33F6F0A6AF5FQ34378716-48F8E13A-94A2-43E3-A1E0-9274E73C17BBQ34393557-FEC3EABD-AC87-4EFD-B6C6-3009FF517D74Q34394557-DD165D2D-4E60-46D1-8DCF-5A92946627E8Q34526755-CE0A99AB-43AE-4420-90D6-B6759275501DQ35177434-553272BB-563B-47D5-9CFA-8597A1C14C80Q35208078-0AD8AACA-E751-4D54-B718-C67956935D7FQ35556908-EEC0BD30-3ADF-4237-843F-218052542193Q35683401-9312FD56-FD39-4426-BBE6-510184B4B38AQ35720755-1922BC38-AD5D-4714-83B1-0803743367B9Q36042640-433DB73F-E349-4BA1-9DBA-D073D88E5ECDQ36043718-973244C0-38A6-43FF-9718-0D483D75864FQ36287335-D2B78D96-ADE9-4EBE-AEDF-CA552377C874Q36402212-58B214F0-813F-4E89-9046-8CB9171EDFDFQ36496478-0E37BD0B-5969-439A-B082-A20B16FD9E12Q36700100-FFF2E8C4-00CC-4D06-BC7F-F34F002DBA66Q37018902-419268B2-07A1-46CB-8380-7D6EE1385426Q37237357-CEC92AA3-15E6-45B5-85C9-2D127EC000DEQ37742528-B26A38B6-7EEA-4DDF-8494-86D4353B8897Q40042946-3A344C2E-DB34-450B-8FAA-81080CC14972Q40096108-D82EEC5F-4218-4E85-BCB1-5076151BEB25Q40509239-396F1510-3C18-4A81-B6D9-45699AD93B8FQ40702250-3F5EC716-08EA-4C39-B562-29964DDF6F8CQ40920093-A7B4AC5B-E7F4-46B9-9740-3EB493249584Q41201776-F9F28B75-3C40-4255-94A0-1E09534329E6Q41512220-4FD806F2-3F68-4ACF-B4CB-E34B79DF09E8Q41835579-21F359D7-C7D1-44D9-B193-EDC482A4812BQ42456864-0F988C6A-0455-4C71-9F1B-C6149941741AQ43185729-065AF2AF-2655-4C27-9A36-E6000F9C1627Q43552157-050FB6E4-2102-4BE5-B87E-A95581230FC4Q43953722-B562C4EA-1652-41C4-ABC7-AE9E6D16FBCCQ44452085-7D74433B-07F9-473F-9779-F9A04B853351Q44928064-A9C90E55-DA7E-4D7B-9C0C-FB8A3EF54C41Q46527244-6744E872-185B-48BD-AA8C-610E5CC9715BQ48425806-AD4B8ED9-C459-4EA2-B2D5-2B1E1EDB5BD6
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Prostaglandins from tumours of human large bowel.
@ast
Prostaglandins from tumours of human large bowel.
@en
type
label
Prostaglandins from tumours of human large bowel.
@ast
Prostaglandins from tumours of human large bowel.
@en
prefLabel
Prostaglandins from tumours of human large bowel.
@ast
Prostaglandins from tumours of human large bowel.
@en
P2093
P2860
P356
P1476
Prostaglandins from tumours of human large bowel.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1977.132
P407
P577
1977-06-01T00:00:00Z
P5875
P6179
1020628528